These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 7959202)
1. A budesonide prodrug accelerates treatment of colitis in rats. Cui N; Friend DR; Fedorak RN Gut; 1994 Oct; 35(10):1439-46. PubMed ID: 7959202 [TBL] [Abstract][Full Text] [Related]
2. Colonic delivery of dexamethasone from a prodrug accelerates healing of colitis in rats without adrenal suppression. Fedorak RN; Haeberlin B; Empey LR; Cui N; Nolen H; Jewell LD; Friend DR Gastroenterology; 1995 Jun; 108(6):1688-99. PubMed ID: 7768373 [TBL] [Abstract][Full Text] [Related]
3. A glucocorticoid prodrug facilitates normal mucosal function in rat colitis without adrenal suppression. McLeod AD; Fedorak RN; Friend DR; Tozer TN; Cui N Gastroenterology; 1994 Feb; 106(2):405-13. PubMed ID: 7507873 [TBL] [Abstract][Full Text] [Related]
4. Topical anticolitic efficacy and selectivity of the glucocorticoid budesonide in a new model of acetic acid-induced acute colitis in the rat. Fabia R; Ar'Rajab A; Willén R; Brattsand R; Erlansson M; Svensjö E Aliment Pharmacol Ther; 1994 Aug; 8(4):433-41. PubMed ID: 7986968 [TBL] [Abstract][Full Text] [Related]
5. Budesonide-beta-D-glucuronide: a potential prodrug for treatment of ulcerative colitis. Nolen H; Fedorak RN; Friend DR J Pharm Sci; 1995 Jun; 84(6):677-81. PubMed ID: 7562403 [TBL] [Abstract][Full Text] [Related]
6. A novel colon-specific steroid prodrug enhances sodium chloride absorption in rat colitis. Fedorak RN; Cui N; Friend DR; Madsen KL; Empey LR Am J Physiol; 1995 Aug; 269(2 Pt 1):G210-8. PubMed ID: 7653560 [TBL] [Abstract][Full Text] [Related]
7. Dexamethasone 21-sulfate improves the therapeutic properties of dexamethasone against experimental rat colitis by specifically delivering the steroid to the large intestine. Kim I; Kong H; Lee Y; Hong S; Han J; Jung S; Jung Y; Kim YM Pharm Res; 2009 Feb; 26(2):415-21. PubMed ID: 18958401 [TBL] [Abstract][Full Text] [Related]
8. Steady-state pharmacokinetics of corticosteroid delivery from glucuronide prodrugs in normal and colitic rats. Nolen HW; Fedorak RN; Friend DR Biopharm Drug Dispos; 1997 Nov; 18(8):681-95. PubMed ID: 9373725 [TBL] [Abstract][Full Text] [Related]
9. The mechanism of altered neural function in a rat model of acute colitis. Jacobson K; McHugh K; Collins SM Gastroenterology; 1997 Jan; 112(1):156-62. PubMed ID: 8978354 [TBL] [Abstract][Full Text] [Related]
10. Effectiveness of budesonide-succinate-dextran conjugate as a novel prodrug of budesonide against acetic acid-induced colitis in rats. Varshosaz J; Emami J; Fassihi A; Tavakoli N; Minaiyan M; Ahmadi F; Mahzouni P; Dorkoosh F Int J Colorectal Dis; 2010 Oct; 25(10):1159-65. PubMed ID: 20669022 [TBL] [Abstract][Full Text] [Related]
11. Colon-specific delivery of budesonide from microencapsulated cellulosic cores: evaluation of the efficacy against colonic inflammation in rats. Rodriguez M; Antúnez JA; Taboada C; Seijo B; Torres D J Pharm Pharmacol; 2001 Sep; 53(9):1207-15. PubMed ID: 11578103 [TBL] [Abstract][Full Text] [Related]
12. Antibiotic treatment with ampicillin accelerates the healing of colonic damage impaired by aspirin and coxib in the experimental colitis. Importance of intestinal bacteria, colonic microcirculation and proinflammatory cytokines. Zwolinska-Wcislo M; Krzysiek-Maczka G; Ptak-Belowska A; Karczewska E; Pajdo R; Sliwowski Z; Urbanczyk K; Drozdowicz D; Konturek SJ; Pawlik WW; Brzozowski T J Physiol Pharmacol; 2011 Jun; 62(3):357-68. PubMed ID: 21893697 [TBL] [Abstract][Full Text] [Related]
13. In vitro evaluation of dexamethasone-beta-D-glucuronide for colon-specific drug delivery. Haeberlin B; Rubas W; Nolen HW; Friend DR Pharm Res; 1993 Nov; 10(11):1553-62. PubMed ID: 8290467 [TBL] [Abstract][Full Text] [Related]
14. Synthesis and evaluation of dextran-budesonide conjugates as colon specific prodrugs for treatment of ulcerative colitis. Varshosaz J; Emami J; Tavakoli N; Fassihi A; Minaiyan M; Ahmadi F; Dorkoosh F Int J Pharm; 2009 Jan; 365(1-2):69-76. PubMed ID: 18804521 [TBL] [Abstract][Full Text] [Related]
15. The glucocorticoid budesonide has protective and deleterious effects in experimental colitis in mice. Ocón B; Aranda CJ; Gámez-Belmonte R; Suárez MD; Zarzuelo A; Martínez-Augustin O; Sánchez de Medina F Biochem Pharmacol; 2016 Sep; 116():73-88. PubMed ID: 27431777 [TBL] [Abstract][Full Text] [Related]
16. Glycyrrhizin enhances therapeutic activity of a colon-specific methylprednisolone prodrug against experimental colitis. Lee Y; Jeong S; Kim W; Kim H; Yoon JH; Jeong SH; Jung Y Dig Dis Sci; 2013 May; 58(5):1226-34. PubMed ID: 23192646 [TBL] [Abstract][Full Text] [Related]
17. Indomethacin worsens and a leukotriene biosynthesis inhibitor accelerates mucosal healing in rat colitis. Empey LR; Walker K; Fedorak RN Can J Physiol Pharmacol; 1992 May; 70(5):660-8. PubMed ID: 1330256 [TBL] [Abstract][Full Text] [Related]
18. Therapeutic switching of sulpiride, an anti-psychotic and prokinetic drug, to an anti-colitic drug using colon-specific drug delivery. Kim D; Kim W; Jeong S; Kim D; Yoo JW; Jung Y Drug Deliv Transl Res; 2019 Feb; 9(1):334-343. PubMed ID: 30426357 [TBL] [Abstract][Full Text] [Related]
19. Colonic delivery of celecoxib is a potential pharmaceutical strategy for repositioning the selective COX-2 inhibitor as an anti-colitic agent. Kim W; Lee Y; Jeong S; Nam J; Lee S; Jung Y Arch Pharm Res; 2015 Oct; 38(10):1830-8. PubMed ID: 25860026 [TBL] [Abstract][Full Text] [Related]